Yield10 Bioscience Stock Investor Sentiment
| YTEN Stock | USD 0.28 0.03 9.68% |
About 72% of Yield10 Bioscience's investor base is looking to short. The analysis of the overall investor sentiment regarding Yield10 Bioscience suggests that many traders are alarmed. Yield10 Bioscience's investor sentiment overview provides quick insight into current market opportunities from investing in Yield10 Bioscience. The current market sentiment, together with Yield10 Bioscience's historical and current headlines, can help investors time the market. In addition, many technical investors use Yield10 Bioscience stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Yield10 Bioscience stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Yield10 daily returns and investor perception about the current price of Yield10 Bioscience as well as its diversification or hedging effects on your existing portfolios.
Yield10 |
Yield10 Bioscience Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Yield10 Bioscience can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Yield10 Bioscience that are available to investors today. That information is available publicly through Yield10 media outlets and privately through word of mouth or via Yield10 internal channels. However, regardless of the origin, that massive amount of Yield10 data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Yield10 Bioscience news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Yield10 Bioscience relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Yield10 Bioscience's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Yield10 Bioscience alpha.
Yield10 Bioscience Performance against NYSE Composite
Price Growth (%) |
| Timeline |
1 | Satellos Announces Promising Preliminary Data in Facioscapulohumeral Muscular Dystrophy | 02/13/2024 |
2 | Acquisition by Lynne Brum of 100000 shares of Yield10 Bioscience at 0.3 subject to Rule 16b-3 | 02/15/2024 |
3 | Acquisition by Van Nostrand Robert L of 10000 shares of Yield10 Bioscience subject to Rule 16b-3 | 02/23/2024 |
4 | Ultra-processed foods Largest ever review shows many ill effects on health | 03/04/2024 |
5 | Satellos to Participate in the Leerink Partners Global Biopharma Conference 2024 | 03/05/2024 |
6 | Disposition of 988 shares by Kristi Snell of Yield10 Bioscience at 2.68 subject to Rule 16b-3 | 03/08/2024 |
7 | Satellos to Present at Upcoming Virtual Investor Conferences in March and April | 03/14/2024 |
8 | USDA-APHIS Determines that Yield10 Biosciences Omega-3 Camelina VarietiesMay Be Planted and Bred in the United States | 03/21/2024 |
9 | Satellos Bioscience Announces 2023 Year End Financial Results and Operational Highlights | 03/27/2024 |
10 | Earnings call Yield10 Bioscience outlines omega-3 commercialization plan | 04/02/2024 |
11 | Yield10 Bioscience, Inc. Q4 2023 Earnings Call Transcript | 04/05/2024 |
12 | Mabwell Bioscience Full Year 2023 Earnings Misses Expectations | 04/10/2024 |
Check out Yield10 Bioscience Hype Analysis, Yield10 Bioscience Correlation and Yield10 Bioscience Performance. To learn how to invest in Yield10 Stock, please use our How to Invest in Yield10 Bioscience guide.Note that the Yield10 Bioscience information on this page should be used as a complementary analysis to other Yield10 Bioscience's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for Yield10 Stock analysis
When running Yield10 Bioscience's price analysis, check to measure Yield10 Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Yield10 Bioscience is operating at the current time. Most of Yield10 Bioscience's value examination focuses on studying past and present price action to predict the probability of Yield10 Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Yield10 Bioscience's price. Additionally, you may evaluate how the addition of Yield10 Bioscience to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |
Is Yield10 Bioscience's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Yield10 Bioscience. If investors know Yield10 will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Yield10 Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.82) | Revenue Per Share 0.008 | Quarterly Revenue Growth (1.00) | Return On Assets (1.50) | Return On Equity (15.08) |
The market value of Yield10 Bioscience is measured differently than its book value, which is the value of Yield10 that is recorded on the company's balance sheet. Investors also form their own opinion of Yield10 Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Yield10 Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Yield10 Bioscience's market value can be influenced by many factors that don't directly affect Yield10 Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Yield10 Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Yield10 Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Yield10 Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.